当前位置:首页 - 行情中心 - 迈克生物(300463) - 财务分析

迈克生物

(300463)

  

流通市值:57.20亿  总市值:70.32亿
流通股本:4.92亿   总股本:6.05亿

迈克生物(300463)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.37亿元,每股收益0.06元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益637228.66万元,未分配利润384392.39万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产801081.36万元,负债163852.70万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,075,034,096.39510,257,588.92,548,756,678.61,947,615,476.64
营业总成本1,006,684,937.26466,928,768.322,321,458,650.011,641,999,626.83
其他经营收益
营业利润55,638,080.2234,523,350.03169,965,453.93318,543,422.7
利润总额28,409,089.6129,439,884.35124,651,405.31311,283,761.28
净利润36,539,905.5725,453,793.22118,764,333.49283,096,995.04
每股收益
其他综合收益-15,121,818.95-14,790,104.16-712,340.23-9,042,783.88
综合收益总额21,418,086.6210,663,689.06118,051,993.26274,054,211.16
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计3,554,900,187.23,683,847,388.763,639,623,036.943,902,000,019.17
非流动资产:
非流动资产合计4,455,913,445.344,378,449,326.464,336,683,700.164,303,887,200.63
资产总计8,010,813,632.548,062,296,715.227,976,306,737.18,205,887,219.8
流动负债:
流动负债合计1,016,981,836.521,243,711,014.761,195,958,828.31,238,842,033.81
非流动负债:
非流动负债合计621,545,187.24390,551,228.17356,685,361.78348,695,917.07
负债合计1,638,527,023.761,634,262,242.931,552,644,190.081,587,537,950.88
所有者权益(或股东权益):
归属于母公司股东权益合计6,322,440,254.336,379,211,356.916,369,056,728.786,535,187,860.09
股东权益合计6,372,286,608.786,428,034,472.296,423,662,547.026,618,349,268.92
负债和股东权益合计8,010,813,632.548,062,296,715.227,976,306,737.18,205,887,219.8
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,355,589,579.14674,117,346.673,079,455,479.52,304,098,579.13
经营活动现金流出小计1,193,799,946.12618,550,399.572,445,656,921.881,811,099,189.49
经营活动产生的现金流量净额161,789,633.0255,566,947.1633,798,557.62492,999,389.64
投资活动产生的现金流量:
投资活动现金流入小计89,807,397.0376,835,834.13865,545,694.85598,620,038.46
投资活动现金流出小计410,607,484.42175,314,884.361,543,016,438.541,138,860,856.72
投资活动产生的现金流量净额-320,800,087.39-98,479,050.23-677,470,743.69-540,240,818.26
筹资活动产生的现金流量:
筹资活动现金流入小计700,376,722.6266,591,057.03685,898,664.18580,793,037.56
筹资活动现金流出小计530,951,041.35102,404,646.83812,676,944.23536,827,366.03
筹资活动产生的现金流量净额169,425,681.25164,186,410.2-126,778,280.0543,965,671.53
汇率变动对现金及现金等价物的影响523,487.4176,572.03191,911.66-2,028,700.86
现金及现金等价物净增加额10,938,714.29121,350,879.1-170,258,554.46-5,304,457.95
期末现金及现金等价物余额652,042,454.26762,454,619.07641,103,739.97806,057,836.48
补充资料:
现金及现金等价物的净增加额10,938,714.29--170,258,554.46-
最新报告期:2025-08-01
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华泰证券代雯,高鹏,杨昌源0.350.420.532025-08-01
TOP↑